CBT
JUNO

Capital Bank & Trust’s Juno Therapeutics, Inc. JUNO Stock Holding History

Capital Bank & Trust’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-193,478
Closed -$8.84M – 727
2017
Q4 		$8.84M Buy
193,478
+3,618
+2% +$180K 0.12% 127
2017
Q3 		$8.52M Buy
+189,860
New +$6.47M 0.11% 127

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Capital Bank & Trust's JUNO Position: Q1 2018 in Review

Capital Bank & Trust sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 193,478 shares — an estimated $8.84M sold.

Capital Bank & Trust first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $8.84M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Capital Bank & Trust reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Capital Bank & Trust sold 193,478 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $8.84M.
  • Capital Bank & Trust first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Capital Bank & Trust's Juno Therapeutics, Inc. position peaked at $8.84M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Capital Bank & Trust's 13F filing for Q1 2018, filed 15 May 2018.